Curexa ® Pharmacy dispensing Mavyret ™ for the treatment of chronic...

Curexa® Pharmacy proudly announces the availability of MAVYRET™. MAVYRET™ (glecaprevir and pibrentasvir) is a newly approved chronic Hepatitis C oral therapy.(PRWeb August 28, 2017)Read the full story at http://www.prweb.com/releases/2017/08/prweb14634795.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news